For retail sale medicaments with insulin or hormones or antibiotics market in Belgium

Earlier Report Observations

The market for retail-packed insulin, hormone, and antibiotic medicaments in Belgium expanded from 1 638 млн долл. США in 2018 to 1 887 млн долл. США in 2019. By 2022, market size reached 2 068 млн долл. США, supported by a robust pharmaceutical sector where major players like Sanofi, Pfizer, and Novartis contributed to overall industry turnover.

A sharp contraction to 1 204 млн долл. США occurred in 2023, primarily due to widespread drug shortages reported by the Belgian Pharmaceutical Association, which limited the availability of insulin and other essential medicines. The market partially recovered to 1 317 млн долл. США in 2024, driven by regulatory reforms that allowed wholesalers to import non-authorized medicines during critical shortages and by new legislation aimed at accelerating access to innovative drugs.

Production for retail sale medicaments with insulin or hormones or antibiotics in Belgium

In value, 2017-2020, M $ US

Belgium's production of retail sale medicaments containing insulin, hormones, or antibiotics grew for the second consecutive year. In 2019, output reached 2 378 million US dollars, marking a 4.1% increase compared to 2018. Over the 2017-2019 period, production rose by 60.5%, with a compound annual growth rate of 17.1%.

Annual dynamics of production in Belgium in value, 2017-2020, M $ US

Exports for retail sale medicaments with insulin or hormones or antibiotics from Belgium

Exports in kind, t

After two years of growth, Belgium's export volume of retail sale medicaments with insulin, hormones, or antibiotics declined. In 2020, Belgium exported 4 661 tonnes, showing a modest contraction of 4.1% compared to 2019. The peak was recorded in 2019 at 4 860 tonnes, while the largest increase occurred in 2018 at 3.8%.

Annual dynamics of product's exports from Belgium in kind, 2017-2020, t

From 2017 to 2020, Belgium's exports in kind of retail sale medicaments containing insulin, hormones, or antibiotics were widely distributed across markets. China accounted for 18.2% of exports, the United States for 9.8%, and the United Kingdom for 6.8%, together making up only 34.8% of total flows.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Belgium in kind, 2017-2020

Exports in value, M $ US

Belgium's exports of retail sale medicaments with insulin, hormones, or antibiotics increased for the third consecutive year. In 2020, exports totaled 3 371 million US dollars, representing a 4.6% year-on-year improvement. Over the 2017-2020 period, exports grew by 28.8%, with a compound annual growth rate of 8.8%.

Annual dynamics of product's exports from Belgium in value, 2017-2020, M $ US

Throughout 2017-2020, Belgium's exports in value terms of retail sale medicaments containing insulin, hormones, or antibiotics were not concentrated on a few key markets. Italy accounted for 18.9% of exports, Germany for 11.9%, and the United States for 9.4%, jointly representing only 40.1% of total flows.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Belgium in value, 2017-2020

Imports for retail sale medicaments with insulin or hormones or antibiotics to Belgium

Imports in kind, t

Belgium's imports of retail sale medicaments with insulin, hormones, or antibiotics rose for the third consecutive year. In 2020, imports reached 6 845 tonnes, reflecting a sharp uptick of 42.3% from the previous year. Between 2017 and 2020, imports increased by 147.8%, equating to an annualized growth rate of 35.3%.

Annual dynamics of product's imports to Belgium in kind, 2017-2020, t

From 2017 to 2020, the Netherlands led as the top supplier of retail sale medicaments containing insulin, hormones, or antibiotics to Belgium, accounting for 35.5% of imports in kind. France followed with 17.3%, and Italy with 14.6%, together reaching 67.4% of total imports.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Belgium in kind, 2017-2020

Imports in value, M $ US

Belgium's import volume of retail sale medicaments with insulin, hormones, or antibiotics increased for the third consecutive year. In 2020, import volume amounted to 3 042 million US dollars, up by 11.3% compared to the previous year. Over the 2017-2020 period, imports grew by 65.8%, with a compound annual growth rate of 18.3%.

Annual dynamics of product's imports to Belgium in value, 2017-2020, M $ US

Throughout 2017-2020, Italy, Germany, and Ireland remained the three largest markets for Belgium's imports in value terms, together accounting for 81.4% of total flows.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Belgium in value, 2017-2020